help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russo, J.
Right arrow Articles by Russo, I. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russo, J.
Right arrow Articles by Russo, I. H.

American Journal of Pathology, Vol 100, 497-512, Copyright © 1980 by American Society for Investigative Pathology


REGULAR ARTICLES

Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence

J Russo and IH Russo

In the rat, pregnancy and lactation prior to carcinogen administration protect the mammary gland from developing carcinomas and benign lesions. In this study, the influence of pregnancy interruption versus full pregnancy and pregnancy plus lactation on the incidence of carcinomas and benign lesions was studied in the mammary glands of rats treated with 7,12-dimethylbenz(a)anthracene (DMBA). Fifty-nine Sprague- Dawley rats were separated into 5 groups: I) rats that had had one pregnancy and one lactation; II) rats that had had one pregnancy without lactation; III) rats that had had pregnancy interrupted at the 12th day of gestation; IV) age-matched virgin rats as a control Group I; and V) age-matched virgin rats as a control for groups II and III. The 5 groups received a single intragastric dose of DMBA (10 mg/100 g body weight), with the exception of 2 animals per group, which were killed 1 hour after an intraperitoneal injection of 2.5 mu Ci 3H- thymidine/g body weight. The number of labeled nuclei per 100 cells (DNA labeling index, LI) was counted in terminal end buds (TEBs), terminal ducts (TDs), and alveolar buds (ABs) of the glands. The number of structures and the DNA-LI were correlated with the incidence of tumors at 22 weeks after DMBA. Pregnancy, with or without lactation, resulted in elimination of TEBs and reduction in the DNA-LI of TDs and ABs. These groups did not develop carcinomas. After the interruption of pregnancy the mammary gland contained numerous TEBs, with a high DNA- LI; 77% of these animals developed carcinomas, and all of them developed benign lesions. Therefore, while pregnancy and lactation protected the mammary gland from developing carcinomas and benign lesions by induction of full differentiation, pregnancy interruption did not elicit sufficient differentiation in the gland to be protective, and these animals were at the same risk as virgin animals treated with the carcinogen.


This article has been cited by other articles:


Home page
Cancer Res.Home page
C. R. Loehberg, T. Thompson, M. B. Kastan, K. H. Maclean, D. G. Edwards, F. S. Kittrell, D. Medina, O. M. Conneely, and B. W. O'Malley
Ataxia Telangiectasia-Mutated and p53 Are Potential Mediators of Chloroquine-Induced Resistance to Mammary Carcinogenesis
Cancer Res., December 15, 2007; 67(24): 12026 - 12033.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. B. Michels, F. Xue, G. A. Colditz, and W. C. Willett
Induced and Spontaneous Abortion and Incidence of Breast Cancer Among Young Women: A Prospective Cohort Study
Arch Intern Med, April 23, 2007; 167(8): 814 - 820.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Mukhina, D. Liu, K. Guo, M. Raccurt, S. Borges-Bendris, H. C. Mertani, and P. E. Lobie
Autocrine Growth Hormone Prevents Lactogenic Differentiation of Mouse Mammary Epithelial Cells
Endocrinology, April 1, 2006; 147(4): 1819 - 1829.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
D. Medina
Mammary developmental fate and breast cancer risk
Endocr. Relat. Cancer, September 1, 2005; 12(3): 483 - 495.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
D. H Brewster, D. L Stockton, R. Dobbie, D. Bull, and V. Beral
Risk of breast cancer after miscarriage or induced abortion: a Scottish record linkage case-control study
J. Epidemiol. Community Health, April 1, 2005; 59(4): 283 - 287.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. NILSEN-HAMILTON, Q. LIU, J. RYON, L. BENDICKSON, P. LEPONT, and Q. CHANG
Tissue Involution and the Acute Phase Response
Ann. N.Y. Acad. Sci., May 1, 2003; 995(1): 94 - 108.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. R. Ginger, M. F. Gonzalez-Rimbau, J. P. Gay, and J. M. Rosen
Persistent Changes in Gene Expression Induced by Estrogen and Progesterone in the Rat Mammary Gland
Mol. Endocrinol., November 1, 2001; 15(11): 1993 - 2009.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Sivaraman, O. M. Conneely, D. Medina, and B. W. O'Malley
p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis
PNAS, October 12, 2001; (2001) 221459098.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Thordarson, K. Van Horn, R. C. Guzman, S. Nandi, and F. Talamantes
Parous rats regain high susceptibility to chemically induced mammary cancer after treatment with various mammotropic hormones
Carcinogenesis, July 1, 2001; 22(7): 1027 - 1033.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. Medina and G. H. Smith
Chemical Carcinogen-Induced Tumorigenesis in Parous, Involuted Mouse Mammary Glands
J Natl Cancer Inst, June 2, 1999; 91(11): 967 - 969.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Yang, K. Yoshizawa, S. Nandi, and A. Tsubura
Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats
Carcinogenesis, April 1, 1999; 20(4): 623 - 628.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y.-C. Chou, R. C. Guzman, S. M. Swanson, J. Yang, H. M. Lui, V. Wu, and S. Nandi
Induction of mammary carcinomas by N-methyl-N-nitrosourea in ovariectomized rats treated with epidermal growth factor
Carcinogenesis, April 1, 1999; 20(4): 677 - 684.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
S. Mehigan
Induced abortion did not increase the risk of breast cancer
Evid. Based Nurs., January 1, 1998; 1(1): 21 - 21.
[Full Text]


Home page
NEJMHome page
J. Brind, V. M. Chinchilli, R. E. Senghas, M. F. Dolan, M. Melbye, J. Wohlfahrt, and P. K. Andersen
Induced Abortion and the Risk of Breast Cancer
N. Engl. J. Med., June 19, 1997; 336(25): 1834 - 1835.
[Full Text]


Home page
NEJMHome page
M. Melbye, J. Wohlfahrt, J. H. Olsen, M. Frisch, T. Westergaard, K. Helweg-Larsen, and P. K. Andersen
Induced Abortion and the Risk of Breast Cancer
N. Engl. J. Med., January 9, 1997; 336(2): 81 - 85.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Sivaraman, O. M. Conneely, D. Medina, and B. W. O'Malley
p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis
PNAS, October 23, 2001; 98(22): 12379 - 12384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American Society for Investigative Pathology.